- Foreign portfolio investors' exodus continues for 9th month; withdraw Rs 50,203 cr from equity market in June - know reasons
- Windfall tax to recoup most of Rs 1 lakh cr revenue lost in excise cuts, industry sources say
- D-Mart Q1 revenue jumps almost 2-fold to Rs 9,806.89 cr
- This Android malware switches off Wi-Fi and drain mobile wallet
- North Korea says US, South Korea-Japan agreement materialises US plan for 'Asian NATO'
Trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy''s
Drugmaker Dr Reddy`s Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russia`s coronavirus vaccine candidate, with the late-stage expected to be completed by as early as March 2021.
Drugmaker Dr Reddy`s Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russia`s coronavirus vaccine candidate, Sputnik-V, with the late-stage expected to be completed by as early as March 2021.
Chief Executive Officer Erez Israeli said enrolment to the mid-stage trial of the Sputnik-V vaccine will start in the next few weeks and the trial was likely to end by December.
"(Phase 3 trial) can be over as fast as the end of March, but it could go into April or May," Israeli said on a post-earnings press briefing, adding the timeline will depend on the Phase 2 trial results and further approvals from authorities.
With 8 million COVID-19 infections and second only to the United States, India is pinning its hopes on a vaccine to stem the spread of the pandemic.
The ongoing festive season and a state assembly election are seen by healthcare experts as adding to the challenges in containing the outbreak.
The Hyderabad-based company had received renewed approval for late-stage clinical trials in India of the Sputnik-V vaccine earlier this month, after initially signing a deal with the Russian Direct Investment Fund in September.
The company expects to enrol 100 participants for the mid-stage trial and 1,500 people for the late-stage.
Shares of the company closed 2.9% lower at 4,951 rupees in a weak Mumbai market after Dr Reddy`s reported https://bit.ly/31PkFO8 a 30.3% fall in consolidated net profit after tax from a year earlier. Net sales, however, jumped to 47.77 billion rupees from 39.98 billion rupees a year ago.
The drugmaker, which last week isolated all its data centre services as a preventive measure following a cyberattack, said it was a ransomware attack, but was yet to ascertain if any personal information was accessed.
The story has been taken from a news agency
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.